REVIVAL-2 - REVIVAL-2

Description:

The goal of the trial was to evaluate treatment with stem cell mobilization by granulocyte-colony stimulating factors (G-CSFs) compared with placebo among patients with acute myocardial infarction (MI) who had successful reperfusion with primary percutaneous coronary intervention (PCI).